e-FabRIC is an EU-funded project aiming to develop an innovative broad-spectrum pan-Sarbecovirus therapy dedicated to pandemic preparedness. Sarbecoviruses are a subgenus within Betacoronavirus and have

In January, members of the e-FabRIC consortium met in Madrid for the third time to review ongoing activities and refine the project’s strategic roadmap. This

In the wake of COVID-19, the world has come to a collective realization: our preparedness for pandemics must be strengthened—not just nationally, but globally. In

In January, the consortium of e-FabRIC convened in Antwerp to discuss the progress and future direction of the project. The meeting provided an opportunity for

The Howarth Group at the University of Cambridge, a partner at e-FabRIC, has manufactured and delivered an innovative mosaic antigen, obtained from the conjugation of

We are pleased to announce the official launch of e-FabRIC on January 22, 2024. This significant milestone was marked by a pivotal kick-off meeting held